Background A regional trial indicated that implementing at-risk asthma registers in primary care could reduce hospital ...
Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...
Determinants of declining lung function trajectories from childhood to adulthood after preterm birth
Background Preterm birth is associated with lifelong respiratory sequelae, yet our understanding of lung function ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Non-invasive ventilation (NIV) is a cornerstone of respiratory management in amyotrophic lateral sclerosis (ALS), extending survival and relieving symptoms of respiratory failure.1 2 However, ALS has ...
Pulmonary rehabilitation programmes, typically 8 weeks or longer in duration, deliver patient-tailored therapies including but not limited to exercise training, education and behaviour change to ...
Correspondence to Prof. Min Yu, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, Zhejiang, China; mycdc1234{at}163.com; Dr Yingjun Li, Department of Epidemiology and ...
A patient developed fever, bronchoconstriction, hypoxaemia, pulmonary infiltrates, and serum and bronchoalveolar lavage fluid eosinophilia on two occasions after inhaling crack cocaine. Transbronchial ...
Dr JT Murchison, Department of Clinical Imaging, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh. EH3 9YW, UK. The computed tomographic (CT) pulmonary angiogram appearances of acute right ...
Thoracic Oncology Unit, Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK Correspondence to: Dr M D Peake Thoracic Oncology Unit and Institute for Lung Health, Department of ...
Department of Medicine, Princess Royal Hospital, Haywards Heath, West Sussex, UK Correspondence to Dr Bethan Davies, Department of Medicine, Princess Royal Hospital, Haywards Heath, West Sussex RH16 ...
Background: Roflumilast is a targeted oral once-daily administered phosphodiesterase 4 (PDE4) inhibitor with clinical efficacy in chronic obstructive pulmonary disease (COPD). Results from in vitro ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results